{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:49:57Z","timestamp":1774630197893,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"DOI":"10.7759\/cureus.105981","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:51:42Z","timestamp":1774626702000},"source":"Crossref","is-referenced-by-count":0,"title":["A Cross-Sectional Study of CD163 Expression and CD8-Positive Tumor-Infiltrating Lymphocytes in Glial Tumors at a Tertiary Care Center"],"prefix":"10.7759","author":[{"given":"Aditya","family":"Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naval","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1605346","article-title":"Research landscape of glioma and inflammation over the past two decades","volume":"16","author":"Chen X","year":"2025","unstructured":"Chen X, Wang J, Liu S, Han Q, Zhang H, Wu J. Research landscape of glioma and inflammation over the past two decades. Front Immunol. 2025, 16:1605346. 10.3389\/fimmu.2025.1605346","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.83531","article-title":"The evolution of tumor microenvironment in gliomas and its implication for target therapy","volume":"19","author":"Hu Y","year":"2023","unstructured":"Hu Y, Li Z, Zhang Y, et al.. The evolution of tumor microenvironment in gliomas and its implication for target therapy. Int J Biol Sci. 2023, 19:4311-26. 10.7150\/ijbs.83531","journal-title":"Int J Biol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1601478","article-title":"Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma","volume":"8","author":"Liu S","year":"2019","unstructured":"Liu S, Zhang C, Maimela NR, et al.. Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma. Oncoimmunology. 2019, 8:1601478. 10.1080\/2162402X.2019.1601478","journal-title":"Oncoimmunology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0803-6","article-title":"Immune landscapes associated with different glioblastoma molecular subtypes","volume":"7","author":"Martinez-Lage M","year":"2019","unstructured":"Martinez-Lage M, Lynch TM, Bi Y, et al.. Immune landscapes associated with different glioblastoma molecular subtypes. Acta Neuropathol Commun. 2019, 7:203. 10.1186\/s40478-019-0803-6","journal-title":"Acta Neuropathol Commun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2217\/cns-2017-0037","article-title":"Distribution of tumor-infiltrating immune cells in glioblastoma","volume":"7","author":"Orrego E","year":"2018","unstructured":"Orrego E, Castaneda CA, Castillo M, et al.. Distribution of tumor-infiltrating immune cells in glioblastoma. CNS Oncol. 2018, 7:CNS21. 10.2217\/cns-2017-0037","journal-title":"CNS Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28523-1","article-title":"T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10","volume":"13","author":"Ravi VM","year":"2022","unstructured":"Ravi VM, Neidert N, Will P, et al.. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun. 2022, 13:925. 10.1038\/s41467-022-28523-1","journal-title":"Nat Commun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.162","article-title":"Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma","volume":"110","author":"Han S","year":"2014","unstructured":"Han S, Zhang C, Li Q, et al.. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br J Cancer. 2014, 110:2560-8. 10.1038\/bjc.2014.162","journal-title":"Br J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.650105","article-title":"Crosstalk between tumor-associated microglia\/macrophages and CD8-positive T cells plays a key role in glioblastoma","volume":"12","author":"Tu S","year":"2021","unstructured":"Tu S, Lin X, Qiu J, et al.. Crosstalk between tumor-associated microglia\/macrophages and CD8-positive T cells plays a key role in glioblastoma. Front Immunol. 2021, 12:650105. 10.3389\/fimmu.2021.650105","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.734956","article-title":"A systematic review of the tumor-infiltrating CD8(+) T-cells\/PD-L1 axis in high-grade glial tumors: toward personalized immuno-oncology","volume":"12","author":"Shadbad MA","year":"2021","unstructured":"Shadbad MA, Asadzadeh Z, Hosseinkhani N, et al.. A systematic review of the tumor-infiltrating CD8(+) T-cells\/PD-L1 axis in high-grade glial tumors: toward personalized immuno-oncology. Front Immunol. 2021, 12:734956. 10.3389\/fimmu.2021.734956","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091457","article-title":"TAMing gliomas: unraveling the roles of Iba1 and CD163 in glioblastoma","volume":"17","author":"Fuse H","year":"2025","unstructured":"Fuse H, Zheng Y, Alzoubi I, Graeber MB. TAMing gliomas: unraveling the roles of Iba1 and CD163 in glioblastoma. Cancers (Basel). 2025, 17:4-6. 10.3390\/cancers17091457","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.157612","article-title":"Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression","volume":"7","author":"Najem H","year":"2022","unstructured":"Najem H, Ott M, Kassab C, et al.. Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression. JCI Insight. 2022, 7:26-8. 10.1172\/jci.insight.157612","journal-title":"JCI Insight"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02104-w","article-title":"Phenotypic and spatial heterogeneity of CD8(+) tumour infiltrating lymphocytes","volume":"23","author":"Sun Y","year":"2024","unstructured":"Sun Y, Yinwang E, Wang S, et al.. Phenotypic and spatial heterogeneity of CD8(+) tumour infiltrating lymphocytes. Mol Cancer. 2024, 23:193. 10.1186\/s12943-024-02104-w","journal-title":"Mol Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1331193","article-title":"CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: an immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial","volume":"6","author":"Gomez-Brouchet A","year":"2017","unstructured":"Gomez-Brouchet A, Illac C, Gilhodes J, et al.. CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: an immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial. Oncoimmunology. 2017, 6:e1331193. 10.1080\/2162402X.2017.1331193","journal-title":"Oncoimmunology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/PO.24.00183","article-title":"CD8(+) tumor-infiltrating lymphocytes in head and neck cancer: a review","volume":"8","author":"Contrera KJ","year":"2024","unstructured":"Contrera KJ, Spector ME, Pantanowitz L, et al.. CD8(+) tumor-infiltrating lymphocytes in head and neck cancer: a review. JCO Precis Oncol. 2024, 8:e2400183. 10.1200\/PO.24.00183","journal-title":"JCO Precis Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050486","article-title":"Tumor-infiltrating lymphocytes in the tumor microenvironment of laryngeal squamous cell carcinoma: systematic review and meta-analysis","volume":"9","author":"Rodrigo JP","year":"2021","unstructured":"Rodrigo JP, S\u00e1nchez-Canteli M, L\u00f3pez F, et al.. Tumor-infiltrating lymphocytes in the tumor microenvironment of laryngeal squamous cell carcinoma: systematic review and meta-analysis. Biomedicines. 2021, 9:32-4. 10.3390\/biomedicines9050486","journal-title":"Biomedicines"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110873","article-title":"Tumor-infiltrating lymphocytes: warriors fight against tumors powerfully","volume":"132","author":"Lin B","year":"2020","unstructured":"Lin B, Du L, Li H, Zhu X, Cui L, Li X. Tumor-infiltrating lymphocytes: warriors fight against tumors powerfully. Biomed Pharmacother. 2020, 132:110873. 10.1016\/j.biopha.2020.110873","journal-title":"Biomed Pharmacother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10249-4","article-title":"Programmed death ligand 1 and tumor-infiltrating CD8(+) T lymphocytes are associated with the clinical features in meningioma","volume":"22","author":"Zhang Y","year":"2022","unstructured":"Zhang Y, Wang X, Shi M, Song Y, Yu J, Han S. Programmed death ligand 1 and tumor-infiltrating CD8(+) T lymphocytes are associated with the clinical features in meningioma. BMC Cancer. 2022, 22:1171. 10.1186\/s12885-022-10249-4","journal-title":"BMC Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/475563-a-cross-sectional-study-of-cd163-expression-and-cd8-positive-tumor-infiltrating-lymphocytes-in-glial-tumors-at-a-tertiary-care-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:51:42Z","timestamp":1774626702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/475563-a-cross-sectional-study-of-cd163-expression-and-cd8-positive-tumor-infiltrating-lymphocytes-in-glial-tumors-at-a-tertiary-care-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.105981","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}